Respiratory Drugs: Medicare Part D Spending

• 43medicines with Part D spending (calendar year 2024)

Each number has its full source under its own list below.

1. 1Trelegy ElliptaFluticasone/Umeclidin/Vilanter · $10.52 per unit$5.3 billion
2. 2Breo ElliptaFluticasone/Vilanterol · $6.50 per unit$1.4 billion
3. 3Fluticasone-SalmeterolFluticasone Propion/Salmeterol · $8.70 per unit$409.3 million
4. 4Advair HFAFluticasone Propion/Salmeterol · $28.71 per unit$320.6 million
5. 5Arnuity ElliptaFluticasone Furoate · $7.37 per unit$199.9 million
6. 6Wixela InhubFluticasone Propion/Salmeterol · $1.58 per unit$196.5 million
7. 7Fluticasone Propionate*Fluticasone Propionate · $0.61 per unit$190.8 million
8. 8Montelukast SodiumMontelukast Sodium · $0.17 per unit$136.3 million
9. 9LorbrenaLorlatinib · $485.61 per unit$116.7 million
10. 10Fluticasone Propionate HFAFluticasone Propionate · $20.70 per unit$93.4 million
11. 11Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav · $0.52 per unit$72.3 million
12. 12Advair DiskusFluticasone Propion/Salmeterol · $3.26 per unit$71.2 million
13. 13Fluticasone-VilanterolFluticasone/Vilanterol · $5.61 per unit$67.1 million
14. 14CephalexinCephalexin · $0.32 per unit$57.5 million
15. 15Fluticasone-Salmeterol HFAFluticasone Propion/Salmeterol · $32.22 per unit$32.2 million

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

• Deaths from air pollution
• Fine dust in the air (PM2.5)
• Chronic lung disease (CLRD) death rate

• Infectious diseases
• Smoking
• Sleep
• Allergies
• Influenza
• Oncology
• Cardiovascular
• Pediatric
• Tuberculosis
• Gut health